source
- Boehringer Ingelheim partners with Sino Biopharma on $7 billion cancer drug dealBoehringer Ingelheim announced a partnership with China's Sino Biopharmaceutical to co-develop cancer therapies. The agreement targets antibody-drug conjugates and T-cell engager platforms, with a…
- CVS Health to split into two publicly traded companies, separating pharmacy and insurance unitsCVS Health announced a plan to divide the company into two separate publicly listed entities. One entity will keep the CVS Health name and encompass the pharmacy retail and pharmacy benefit manage…